Joint WHO/UNAIDS annual consultation with pharmaceutical companies and stakeholders on forecasting global demand of antiretroviral drugs for 2013-2016
Meeting report: 25-26 November 2013 Geneva, Switzerland
The World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) Secretariat jointly organized an annual two-day consultation with pharmaceutical companies and stakeholders to present them with the draft forecasts for the demand of antiretroviral (ARV) drugs in 2013–2016.
The consultation was held on 25–26 November 2013 in Geneva, Switzerland, and gathered 70 participants from the innovator and generic drug industry, active pharmaceutical ingredient (API) producers, professionals from partner organizations, a representative from the National Department of Health, South Africa, and civil society and other nongovernmental organizations. This report summarizes the main points discussed during the meeting.